On July 30, Hca Healthcare Inc declined 3.01% in regular trading, trading at $396.675 per share, with turnover of $121 million. The decline was driven by a wave of analyst price target cuts following the company's decision to lower full-year earnings guidance, compounded by broad weakness across the healthcare facilities sector.

Although HCA's Q2 results beat expectations with revenue of $20.23 billion versus the $19.76 billion consensus and adjusted EPS of $7.59 versus $7.56 expected, the company raised its estimated full-year impact from Health Insurance Exchange headwinds to $10-12 billion from the prior $6-9 billion range. Morgan Stanley cut its price target to $380 from $425 while maintaining an Underweight rating, and Mizuho lowered its target to $475 from $525. Barclays previously downgraded the stock to equal weight with a $427 target. Concerns over deteriorating uninsured patient mix persist.

Within the Health Care Facilities sector, peers declined in tandem: Tenet Healthcare fell 3.47%, Universal Health dropped 3.71%, Acadia Healthcare lost 1.32%, and Brookdale Senior Living slid 1.04%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)